SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-013235
Filing Date
2021-05-28
Accepted
2021-05-28 17:13:14
Documents
12
Period of Report
2021-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 32532
  Complete submission text file 0001493152-21-013235.txt   206784

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20210414.xsd EX-101.SCH 3053
3 XBRL LABEL FILE abeo-20210414_lab.xml EX-101.LAB 34238
4 XBRL PRESENTATION FILE abeo-20210414_pre.xml EX-101.PRE 22377
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3725
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-15771 | Film No.: 21981595
SIC: 2834 Pharmaceutical Preparations